Francis M. Bodd

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer”.

Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer

Nature Cancer(2022)10.1038/s43018-022-00416-8

N/A

0.888DataRank · unranked

372 citations

Jia Luo, Andrew Aukerman, Jacklynn V. Egger, Christopher J. Fong, Natally Horvat +16 more

Chromothripsis-Mediated Small Cell Lung Carcinoma

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0286

N/A

0.584DataRank · unranked

48 citations

Sam E. Tischfield, Christopher A. Febres‐Aldana, Jake June-Koo Lee, Jason C. Chang, Benjamin Herzberg +37 more

Comparison of Immunohistochemistry, Next-generation Sequencing and Fluorescence In Situ Hybridization for Detection of MTAP Loss in Pleural Mesothelioma

Modern Pathology(2024)10.1016/j.modpat.2023.100420

N/A

0.442DataRank · unranked

18 citations

Jason C. Chang, Achim A. Jungbluth, Prasad S. Adusumilli, Francis M. Bodd, Denise Frosina +13 more

Neurofibromatosis Type 2-Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif Dual Immunohistochemistry Is a Reliable Marker for the Detection of Neurofibromatosis Type 2 Alterations in Diffuse Pleural Mesothelioma

Modern Pathology(2023)10.1016/j.modpat.2022.100030

N/A

0.396DataRank · unranked

13 citations

Soo‐Ryum Yang, Ying‐Bei Chen, Prasad S. Adusumilli, Ann Bialik, Francis M. Bodd +9 more

Correlation of Histologic Features with Gene Alterations in Pleural Mesothelioma

Modern Pathology(2025)10.1016/j.modpat.2025.100706

N/A

0.292DataRank · unranked

6 citations

Soo‐Ryum Yang, Kay See Tan, Prasad S. Adusumilli, Francis M. Bodd, Anita S. Bowman +10 more

Clinical Significance of MTAP Deletions and Their Overlap With Concurrent Oncogenic Driver Alterations Including EGFR in NSCLC

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.11.010

N/A

0.269DataRank · unranked

5 citations

Rohit Thummalapalli, Christopher A. Febres‐Aldana, Daniel M. Muldoon, Christina J. Falcon, Amanda Pupo +18 more

Reliability of assessing morphologic features with prognostic significance in cytology specimens of epithelioid diffuse pleural mesothelioma and implications for cytopathology reporting

Cancer Cytopathology(2023)10.1002/cncy.22705

N/A

0DataRank · unranked

5 citations

Abeer M. Salama, Marina K. Baine, Francis M. Bodd, Michael Offin, Natasha Rekhtman +5 more

Diagnosis of thoracic SMARCA4‐deficient undifferentiated tumor in cytology

Cancer Cytopathology(2023)10.1002/cncy.22709

N/A

0DataRank · unranked

16 citations

Joseph Montecalvo, Francis M. Bodd, Jason C. Chang, Elyn Riedel, Charlie White +3 more

Dual NF2-YAP/TAZ immunohistochemistry is a reliable marker for the detection of NF2 alterations in diffuse pleural mesothelioma

Research Square(2022)10.21203/rs.3.rs-1720495/v1

N/A

0DataRank · unranked

0 citations

Soo‐Ryum Yang, Ying‐Bei Chen, Prasad S. Adusumilli, Ann Bialik, Francis M. Bodd +9 more